Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR) for Tongue Dysphagia
Muscle Cell Mediated Therapy for Tongue Dysphagia: An Investigation of Cook MyoSite Autologous Muscle Derived Cells
Sponsor: Cook MyoSite
A PHASE1 clinical study on Oropharyngeal Dysphagia, this trial is ongoing. The trial is conducted by Cook MyoSite and has accumulated 17 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
17 versions recorded-
Mar 2025 — Present [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Mar 2025 [monthly]
Recruiting PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE1
-
Nov 2023 — Jul 2024 [monthly]
Recruiting PHASE1
-
Sep 2022 — Nov 2023 [monthly]
Recruiting PHASE1
▶ Show 12 earlier versions
-
Jun 2022 — Sep 2022 [monthly]
Recruiting PHASE1
-
Feb 2022 — Jun 2022 [monthly]
Recruiting PHASE1
-
Dec 2021 — Feb 2022 [monthly]
Recruiting PHASE1
-
Sep 2021 — Dec 2021 [monthly]
Recruiting PHASE1
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE1
-
Aug 2020 — Jan 2021 [monthly]
Recruiting PHASE1
-
Jul 2019 — Aug 2020 [monthly]
Recruiting PHASE1
-
Sep 2018 — Jul 2019 [monthly]
Recruiting PHASE1
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE1
-
Jul 2017 — Jun 2018 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Feb 2017 — Jul 2017 [monthly]
Not Yet Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Cook MyoSite
- Peter Belafsky, MD
For direct contact, visit the study record on ClinicalTrials.gov .